GRI Bio, Inc. (GRI)

GRI Bio Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	11.05	8.23	5.03	1.81	0.01	3.7
Short-Term Investments	-	-	-	-	-	3.81
Cash & Short-Term Investments	11.05	8.23	5.03	1.81	0.01	7.51
Cash Growth	236.73%	63.66%	178.10%	19988.89%	-99.88%	6789.91%
Other Current Assets	0.23	0.36	0.59	1.13	0.3	0.62
Total Current Assets	11.28	8.59	5.62	2.93	0.31	8.13
Net Property, Plant & Equipment	0.06	0.07	0.12	0.02	0.07	-
Other Long-Term Assets	-	-	-	-	-	0.21
Total Assets	11.34	8.67	5.74	2.96	0.38	8.34
Accounts Payable	0.3	1.84	0.9	1.41	1.29	0.92
Accrued Expenses	0.43	0.75	0.69	1.27	0.04	1.43
Short-Term Debt	-	-	-	-	0.6	-
Current Portion of Leases	0.06	0.06	0.05	0.01	0.06	-
Other Current Liabilities	-	-	-	0	0.01	0.1
Total Current Liabilities	0.79	2.64	1.64	2.7	1.99	2.45
Long-Term Leases	-	0.02	0.07	-	0.01	-
Other Long-Term Liabilities	-	-	-	-	-	0.07
Total Long-Term Liabilities	-	0.02	0.07	-	0.01	0.07
Total Liabilities	0.79	2.66	1.71	2.7	2.01	2.52
Additional Paid-in Capital	64.24	57.7	43.77	31.79	16.87	27.72
Accumulated Other Comprehensive Income	-	-	-	-	-	-0
Retained Earnings	-53.69	-51.7	-39.74	-31.53	-18.5	-21.9
Shareholders' Equity	10.55	6.01	4.03	0.26	-1.63	5.82
Total Liabilities & Equity	11.34	8.67	5.74	2.96	0.38	8.34
Total Debt	0.06	0.07	0.12	0.01	0.67	0
Net Cash (Debt)	10.99	8.16	4.91	1.79	-0.66	7.51
Net Cash Growth	34.71%	66.19%	173.63%	-	-	15545.83%
Net Cash Per Share	0.15	0.08	0.75	19.34	-31851.72	360250.59
Book Value	10.55	6.01	4.03	0.26	-1.63	5.82
Book Value Per Share	0.14	0.06	0.62	2.79	-77950.20	279086.00
Tangible Book Value	10.55	6.01	4.03	0.26	-1.63	5.82
Tangible Book Value Per Share	0.14	0.06	0.62	2.79	-77950.20	279086.00

Updated May 13, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q